In particular, methylation of APC1A, APC2, SFRP1, and SFRP2 genes characterized the progression from IBD to IBD-CRC, indicating their potential role as biomarkers for early detection of cancer in IBD patients. The gene discussed is SFRP1; the disease is inflammatory bowel disease.